<div><p>Kaplan-Meier Survival Curves for Mice and Guinea Pigs Given Post-Exposure Treatment for ZEBOV Infection</p><p>(A) Mice (groups of five animals) were infected with 1,000 LD<sub>50</sub> of MA-ZEBOV by i.p. injection. At various times points 24 h prior to challenge (○), 30 min after challenge (♦), or 24 h after challenge (▵) they were treated with 2 × 10<sup>5</sup> pfu of VSVΔG/ZEBOVGP by i.p. injection. The controls (▪) were left untreated and all died. All treated animals survived the challenge.</p><p>(B) Guinea pigs (groups of six animals) were infected with 1,000 LD<sub>50</sub> of GA-ZEBOV by i.p. injection. At various times points 24 h prior to challenge (○), 1 h after challenge (♦), or 24 h after challenge (▵) they were trea...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Vaccinated and mock-vaccinated mice in challenge groups were challenged thorough the intra-vagina...
<p>The durations of survival of mice infected with rVN-PB1(U) (A) and rVN-PB1(C) (B) with increasing...
<div><p>Survival and Plasma Viraemia for Rhesus Monkeys Given Post-Exposure Treatment for ZEBOV Infe...
<p>Kunming mice (17 groups of eight mice, 10–12 g) were infected with ...
<p>A: Survival of guinea pigs having received the anti-EBOV IgGs (n = 10) compared to guinea pigs re...
<p>Mice infected with wild type (green, n = 15), <i>pbggcs-ko</i> (red, n = 10) or <i>pbggcs-oe</i> ...
<p>(A) Plot showing survival of mice after receiving IP injection of A549 cells; median survival of ...
<p>Guinea pigs were infected with 1000 LD<sub>50</sub> of GA-ZEBOV i.p., then treated on 1 dpi with ...
<p>A). Mice immunised with single peptides containing B-epitopes. B). Mice immunised with single pep...
<p>(A) Weight loss. Groups of 5 to 10 four-week-old C57BL/6 mice were infected intranasally with 10<...
<p>A) mouse survival after <i>T. cruzi</i> challenge. Kaplan-Meier curves of (7 to 12 mice per group...
<p>Mice were infected with 4–20 i.n. ECTV LD<sub>50</sub>. (A, B) CPGs treatments with or without VA...
<p><b>(A)</b> Mice were infected i.p. with ~1,000 pfu mouse-adapted EBOV virus and 24 hours later we...
<p>Six-day old mouse pups were challenged with live <i>V. cholerae</i> at a dose of 10 LD<sub>50</su...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Vaccinated and mock-vaccinated mice in challenge groups were challenged thorough the intra-vagina...
<p>The durations of survival of mice infected with rVN-PB1(U) (A) and rVN-PB1(C) (B) with increasing...
<div><p>Survival and Plasma Viraemia for Rhesus Monkeys Given Post-Exposure Treatment for ZEBOV Infe...
<p>Kunming mice (17 groups of eight mice, 10–12 g) were infected with ...
<p>A: Survival of guinea pigs having received the anti-EBOV IgGs (n = 10) compared to guinea pigs re...
<p>Mice infected with wild type (green, n = 15), <i>pbggcs-ko</i> (red, n = 10) or <i>pbggcs-oe</i> ...
<p>(A) Plot showing survival of mice after receiving IP injection of A549 cells; median survival of ...
<p>Guinea pigs were infected with 1000 LD<sub>50</sub> of GA-ZEBOV i.p., then treated on 1 dpi with ...
<p>A). Mice immunised with single peptides containing B-epitopes. B). Mice immunised with single pep...
<p>(A) Weight loss. Groups of 5 to 10 four-week-old C57BL/6 mice were infected intranasally with 10<...
<p>A) mouse survival after <i>T. cruzi</i> challenge. Kaplan-Meier curves of (7 to 12 mice per group...
<p>Mice were infected with 4–20 i.n. ECTV LD<sub>50</sub>. (A, B) CPGs treatments with or without VA...
<p><b>(A)</b> Mice were infected i.p. with ~1,000 pfu mouse-adapted EBOV virus and 24 hours later we...
<p>Six-day old mouse pups were challenged with live <i>V. cholerae</i> at a dose of 10 LD<sub>50</su...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Vaccinated and mock-vaccinated mice in challenge groups were challenged thorough the intra-vagina...
<p>The durations of survival of mice infected with rVN-PB1(U) (A) and rVN-PB1(C) (B) with increasing...